Share This Article:

Adult Primary Prostate Embryonal Rhabdomyosarcoma: Report of a Case and Revue of Literature

Abstract Full-Text HTML Download Download as PDF (Size:806KB) PP. 578-583
DOI: 10.4236/jct.2014.56066    3,721 Downloads   4,652 Views  

ABSTRACT

Introduction: Primary embryonal rhabdomyosarcoma of prostate (ERMP) is an extremely rare pathological and clinical entity in adults. It’s characterized by extensive loco-regional spread and a tendency to metastasize by blood stream and regional lymphatics. In adult patients, data available on the management of ERMP are limited and mostly derived from the pediatric clinical trials on rhabdomyosarcoma. Case Report: We report a case of group III ERMP approached by initial surgery followed by the administration of three courses of vincristine, doxorubicin and Cyclophosphamide regimen. The patient succumbed to disease complications three months after the original diagnosis. Conclusion: The most appropriate therapeutic approach for adults with ERMP remains questionable. Further studies are needed to improve the understanding of biological behavior of ERMP in adults and to define the best therapeutic strategy in locally advanced disease.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Amaadour, L. , Tahiri, Y. , Ameurtesse, H. , Ahssaini, M. , Benbrahim, Z. , Harmouche, T. , Arifi, S. , Ammari, J. and Mellas, N. (2014) Adult Primary Prostate Embryonal Rhabdomyosarcoma: Report of a Case and Revue of Literature. Journal of Cancer Therapy, 5, 578-583. doi: 10.4236/jct.2014.56066.

References

[1] Nabi, G., Dinda, A.K. and Dogra, P.N. (2002) Primary Embryonal Rhabdomyosarcoma of Prostate in Adults: Diagnosis and Management. International Urology and Nephrology, 34, 531-534.
http://dx.doi.org/10.1023/A:1025638711476
[2] Figueiredo, A.A., Brandao, G., Dentz, L.C., Alves, C.M. and Stroppa, A.E. (2007) Bilateral Pulmonary Alveolar Infiltrate and Prostate Tumour in a 54-Year-Old Man. Thorax, 62, 1002-1018.
http://dx.doi.org/10.1136/thx.2007.083717
[3] Waring, P.M. and Newland, R.C. (1992) Prostatic Embryonal Rhabdomyosarcoma in Adults. A Clinicopathologic Review. Cancer, 69, 755-762.
[4] Batsakis, J.G. (1963) Urogenital Rhabdomyosarcoma: Histiogenesis and Classification. Journal of Urology, 90, 180-186.
[5] Kaefer, M. and Rink, R.C. (2000) Genitourinary Rhabdomyosarcoma. Treatment Options. Urologic Clinic of North America, 27, 471-487. http://dx.doi.org/10.1016/S0094-0143(05)70095-1
[6] Ciammella, P., Galeandro, M., D’Abbiero, N., Palmieri, T., Donini, E. and Iotti, C. (2013) Prostate Embryonal Rhabdomyosarcoma in Adults: Case Report and Review of Literature. Reports of Practical Oncology and Radiotherapy, 1, 8310-8315.
[7] Wu, H.-Y. (2009) Genitourinary Rhabdomyosarcoma: Which Treatment, How Much, and When? Journal of Pediatric Urology, 5, 501e-506. http://dx.doi.org/10.1016/j.jpurol.2009.06.011
[8] Klem, M.L., Grewal, R.K., Wexler, L.H., Schoder, H., Meyers, P.A. and Wolden, S.L. (2007) PET for Staging in Rhabdomyosarcoma: An Evaluation of PET as an Adjunct to Current Staging Tools. Journal of Pediatric Hematology/Oncology, 29, 9-14. http://dx.doi.org/10.1097/MPH.0b013e3180307693
[9] Kleis, M., Daldrup-Link, H., Matthay, K., Goldsby, R., Lu, Y., Schuster, T., Schreck, C., Chu, P.W., Hawkins, R.A. and Franc, B.L. (2009) Diagnostic Value of PET/CT for the Staging and Restaging of Pediatric Tumors. European Journal of Nuclear Medicine and Molecular Imaging, 36, 23-36. http://dx.doi.org/10.1007/s00259-008-0911-1
[10] Bisceglia, M., Magro, G., Carosi, I., Cannazza, V. and Ben Dor, D. (2011) Primary Embryonal Rhabdomyosarcoma of the Prostate in Adults: Report of a Case and Review of the Literature. International Journal of Surgical Pathology, 19, 831-837.
http://dx.doi.org/10.1177/1066896910395585
[11] Drake, A.F., Lee, S.C. and Kelley, D.J. (2012) Pathology—Rhabdomyosarcoma. Medscape.
http://emedicine.medscape.com/article/873546-overview#aw2aab6b3
[12] Barr, F.G. (1997) Molecular Genetics and Pathogenesis of Rhabdomyosarcoma. Journal of Pediatric Hematology/Oncology, 19, 483-491. http://dx.doi.org/10.1097/00043426-199711000-00001
[13] Ferrari, A., Dileo, P., Casanova, M., Bertulli, R., Meazza, C., Gandola, L., Navarria, P., Collini, P., Gronchi, A., Olmi, P., Fossati-Bellani, F. and Casali, P.G. (2003) Rhabdomyosarcoma in Adults. A Retrospective Analysis of 171 Patients Treated at a Single Institution. Cancer, 98, 571-580. http://dx.doi.org/10.1002/cncr.11550
[14] Waring, P.M. and Newland, R.C. (1992) Prostatic Embryonal Rhabdomyosarcoma in Adults. A Clinicopathologic Review. Cancer, 69, 755-762. http://dx.doi.org/10.1002/1097-0142(19920201)69:3 <755::AID-CNCR2820690324>3.0.CO;2-Y
[15] Esnaola, N.F., Rubin, B.P., Baldini, E.H., et al. (2001) Response to Chemotherapy and Predictors of Survival in Adult Rhabdomyosarcoma. Annals of Surgery, 234, 215-223.
http://dx.doi.org/10.1097/00000658-200108000-00012
[16] Russo, P. (1991) Urologic Sarcoma in Adults: Memorial Sloan-Kattering Cancer Center Experience Based on a Pros-pective Database between 1982 and 1989. Urologic Clinics of North America, 18, 581-588.
[17] Hays, D.M., Lawrence Jr., W., Crist, W.M., Wiener, E., Raney Jr., R.B., Ragab, A., Teffr, M., Webber, B., Johnston, J., Maurer, H.M. and Intergroup Rhabdomyosarcoma Study (1990) Partial Cystectomy in the Management of Rhabdomyosarcoma of the Bladder: A Report from the Intergroup Rhabdomyosarcoma Study. Journal of Pediatric Surgery, 25, 719-723.
http://dx.doi.org/10.1016/S0022-3468(05)80004-1
[18] Michalkiewicz, E.L., Rao, B.N., Gross, E., et al. (1997) Complications of Pelvic Exenteration in Children Who Have Genitourinary Rhabdomyosarcoma. Journal of Pediatric Surgery, 32, 1277-1282. http://dx.doi.org/10.1016/S0022-3468(97)90301-8
[19] Martelli, H., Oberlin, O., Rey, A., Godzinski, J., Spicer, R.D., Bouvet, N., Haie-Meder, C., Terrier-Lacombe, M.J., Sanchez de Toledo, J., Spooner, D., Sommelet, D., Flamant, F. and Stevens, M.C. (1999) Conservative Treatment for Girls with Nonmetastatic Rhabdomyosarcoma of the Genital Tract: A Report from the Study Committee of the International Society of Pediatric Oncology. Journal of Clinical Oncology, 17, 2117-2122.
[20] Heyn, R., Newton, W.A., Raney, R.B., Hamoudi, A., Bagwell, C., Vietti, T., Wharam, M., Gehan, E. and Maurer, H.M. (1997) Preservation of the Bladder in Patients with Rhabdomyosarcoma. Journal of Clinical Oncology, 15, 69-75.
[21] Crist, W., Gehan, E.A., Ragab, A.H., et al. (1995) The Third Intergroup Rhabdomyosarcoma Study. Journal of Clinical Oncology, 13, 610.
[22] Crist, W.M., Garnsey, L., Beltangady, M.S., Gehan, E., Ruymann, F., Webber, B., Hays, D.M., Wharam, M. and Maurer, H.M. (1990) Prognosis in Children with Rhabdomyosarcoma: A Report of the Intergroup Rhabdomyosarcoma Studies I and II. Intergroup Rhabdomyosarcoma Committee. Journal of Clinical Oncology, 8, 443-452.
[23] Crist, W.M., Anderson, J.R., Meza, J.L., Fryer, C., Raney, R.B., Ruymann, F.B., Breneman, J., Qualman, S.J., Wiener, E., Wharam, M., Lobe, T., Webber, B., Maurer, H.M. and Donaldson, S.S. (2001) Intergroup Rhabdomyosarcoma Study-IV: Results for Patients with Nonmetastatic Disease. Journal of Clinical Oncology, 19, 3091-3102.
[24] (2011) Clinical Trial Information for ARST0531 (NCT00354835).
http://cancer.gov/clinicaltrials/search/view?cdrid=487560&version=healthprofessional
[25] Ferrer, F.A., Isakoff, M. and Koyle, M.A. (2006) Bladder/Prostate Rhabdomyosarcoma: Past, Present and Future. Journal of Urology, 176, 1283-1291. http://dx.doi.org/10.1016/j.juro.2006.06.019
[26] Little, D.J., Ballo, M.T., Zagars, G.K., Pisters, P.W.T., Patel, S.R., El-Naggar, A.K., Garden, A.S. and Benjamin, R.S. (2002) Adult Rhabdomyosarcoma: Outcome Following Multimodality Treatment. Cancer, 95, 377-388. http://dx.doi.org/10.1002/cncr.10669
[27] Arndt, C.A., Stoner, J.A., Hawkins, D.S., Rodeberg, D.A., Hayes-Jordan, A.A., Paidas, C.N., Parham, D.M., Teot, L.A., Wharam, M.D., Breneman, J.C., Donaldson, S.S., Anderson, J.R. and Meyer, W.H. (2009) Vincristine, Actinomycin, and Cyclophosphamide Compared with Vincristine, Actinomycin, and Cyclophosphamide Alternating with Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children’s Oncology Group Study D9803. Journal of Clinical Oncology, 27, 5182-5188. http://dx.doi.org/10.1200/JCO.2009.22.3768
[28] Wharam, M.D., Meza, J., Anderson, J., Breneman, J.C., Donaldson, S.S., Fitzgerald, T.J., Michalski, J., Teot, L.A., Wiener, E.S. and Meyer, W.H. (2004) Failure Pattern and Factors Predictive of Local Failure in Rhabdomyosarcoma: A Report of Group III Patients on the Third Intergroup Rhabdomyosarcoma Study. Journal of Clinical Oncology, 22, 1902-1908. http://dx.doi.org/10.1200/JCO.2004.08.124
[29] Okcu, F., Hicks, J. and Horowitz, M. (2014) Rhabdomyosarcoma and Undifferentiated Sarcoma in Childhood and Adolescence: Treatment. UPTODATE.
[30] Rodeberg, D.A., Stoner, J.A., Hayes-Jordan, A., Kao, S.C., Wolden, S.L., Qualman, S.J., Meyer, W.H. and Hawkins, D.S. (2009) Prognostic Significance of Tumor Response at the End of Therapy in Group III Rhabdomyosarcoma: A Report from the Children’s Oncology Group. Journal of Clinical Oncology, 27, 3705-3711. http://dx.doi.org/10.1200/JCO.2008.19.5933
[31] Godzinski, J., Flamant, F., Rey, A., Praquin, M.T. and Martelli, H. (1994) Value of Postchemotherapy Bioptical Verification of Complete Clinical Remission in Previously Incompletely Resected (Stage I and II pT3) Malignant Mesenchymal Tumors in Children: International Society of Pediatric Oncology 1984 Malignant Mesenchymal Tumors Study. Medical and Pediatric Oncology, 22, 22-26.
http://dx.doi.org/10.1002/mpo.2950220105
[32] Gerber, N.K., Wexler, L.H., Singer, S., Alektiar, K.M., Keohan, M.L., Shi, W.J., Zhang, Z.G. and Wolden, S. (2013) Adult Rhabdomyosarcoma Survival Improved with Treatment on Multimodality Protocols. International Journal of Radiation Oncology * Biology * Physics, 86, 58-63.
http://dx.doi.org/10.1016/j.ijrobp.2012.12.016

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.